Aclaris Therapeutics Shares Outstanding 2014-2019 | ACRS

Aclaris Therapeutics shares outstanding from 2014 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

Aclaris Therapeutics Annual Shares Outstanding (Millions of Shares)
2018	33
2017	28
2016	21
2015	6
2014	2
2013	1

Aclaris Therapeutics Quarterly Shares Outstanding (Millions of Shares)
Q1 2019	41
Q4 2018	33
Q3 2018	31
Q2 2018	31
Q1 2018	31
Q4 2017	28
Q3 2017	29
Q2 2017	27
Q1 2017	26
Q4 2016	21
Q3 2016	21
Q2 2016	21
Q1 2016	20
Q4 2015	6
Q3 2015	2
Q2 2015	2
Q1 2015	2
Q4 2014
Q3 2014	2
Q4 2013

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$0.082B	$0.010B
Aclaris Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing drugs to met needs in dermatology. Its drug candidate consists of A-101, a high-concentration hydrogen peroxide topical solution which is being developed as a prescription treatment for seborrheic keratosis a common non-malignant skin tumor and A-102, a proprietary topical gel dosage form of hydrogen peroxide for the treatment of SK and common warts which are in different clinical trial. Aclaris Therapeutics, Inc. is headquartered in Malvern, Pennsylvania.

Stock Name	Country	Market Cap	PE Ratio
Zoetis (ZTS)	United States	$54.610B	34.89
Astellas Pharma (ALPMY)	Japan	$28.433B	13.94
Takeda Pharmaceutical (TAK)	Japan	$27.154B	7.97
UCB SA (UCBJF)	Belgium	$15.866B	0.00
Eisai (ESALY)	Japan	$15.807B	27.18
Grifols, S.A (GRFS)	Spain	$15.209B	19.24
Merck (MKGAF)	Germany	$13.448B	18.35
IPSEN SA ADR (IPSEY)	France	$10.783B	0.00
Ionis Pharmaceuticals (IONS)	United States	$9.649B	21.09
Sage Therapeutics (SAGE)	United States	$9.439B	0.00
Ono Pharmaceutical (OPHLF)	Japan	$9.254B	19.78
Catalent (CTLT)	United States	$7.912B	31.75
Neurocrine Biosciences (NBIX)	United States	$7.824B	0.00
Jazz Pharmaceuticals (JAZZ)	Ireland	$7.738B	10.61
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF)	Italy	$7.257B	19.83
STADA ARZNEIMI (STDAF)	Germany	$5.634B	0.00
Nektar Therapeutics (NKTR)	United States	$5.573B	9.08
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$5.420B	0.00
Orion OYJ (ORINY)	Finland	$5.275B	27.16
Hypermarcas (HYPMY)	Brazil	$4.805B	16.89
Evotec AG (EVTCY)	Germany	$4.267B	45.80
Tilray (TLRY)	Canada	$4.238B	0.00
FibroGen (FGEN)	United States	$3.983B	0.00
United Therapeutics (UTHR)	United States	$3.300B	0.00
Taro Pharmaceutical Industries (TARO)	Israel	$3.220B	11.56
Arrowhead Pharmaceuticals (ARWR)	United States	$2.766B	416.71
PTC Therapeutics (PTCT)	United States	$2.514B	0.00
Xencor (XNCR)	United States	$2.513B	68.60
Zogenix (ZGNX)	United States	$2.035B	0.00
Portola Pharmaceuticals (PTLA)	United States	$1.814B	0.00
Ironwood Pharmaceuticals (IRWD)	United States	$1.658B	0.00
Pacira Pharmaceuticals (PCRX)	United States	$1.647B	79.76
Enanta Pharmaceuticals (ENTA)	United States	$1.613B	22.04
CLINIGEN GP (CLIGF)	United Kingdom	$1.577B	0.00
USANA Health Sciences (USNA)	United States	$1.462B	12.71
Heron Therapeutics (HRTX)	United States	$1.461B	0.00
Corcept Therapeutics (CORT)	United States	$1.263B	18.03
ArQule (ARQL)	United States	$1.158B	0.00
Aerie Pharmaceuticals (AERI)	United States	$1.062B	0.00
Radius Health (RDUS)	United States	$1.035B	0.00
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$1.016B	3.66
Theravance Biopharma (TBPH)	Cayman Islands	$0.986B	0.00
Spectrum Pharmaceuticals (SPPI)	United States	$0.879B	0.00
Endo (ENDP)	Ireland	$0.740B	1.19
Concordia (CXRXF)	Canada	$0.716B	0.00
Aptorum Group (APM)	China	$0.636B	0.00
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$0.577B	0.00
Crinetics Pharmaceuticals (CRNX)	United States	$0.574B	0.00
Organogenesis Holdings (ORGO)	United States	$0.562B	0.00
TherapeuticsMD (TXMD)	United States	$0.543B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.505B	0.00
GlycoMimetics (GLYC)	United States	$0.482B	0.00
ChemoCentryx (CCXI)	United States	$0.474B	0.00
Translate Bio (TBIO)	United States	$0.472B	0.00
Akebia Therapeutics (AKBA)	United States	$0.457B	0.00
Dova Pharmaceuticals (DOVA)	United States	$0.452B	0.00
Dermira (DERM)	United States	$0.450B	0.00
BioSpecifics Technologies Corp (BSTC)	United States	$0.444B	22.38
Siga Technologies (SIGA)	United States	$0.440B	1.04
Catalyst Pharmaceuticals (CPRX)	United States	$0.417B	0.00
CV Sciences (CVSI)	United States	$0.413B	0.00
Flexion Therapeutics (FLXN)	United States	$0.412B	0.00
Rigel Pharmaceuticals (RIGL)	United States	$0.403B	0.00
CannTrust Holdings (CTST)	Canada	$0.391B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.390B	0.00
Indivior (INVVY)	United States	$0.386B	1.39
BioCryst Pharmaceuticals (BCRX)	United States	$0.374B	0.00
Innate Pharma SA (IPHYF)	France	$0.364B	0.00
Harpoon Therapeutics (HARP)	United States	$0.348B	0.00
ImmunoGen (IMGN)	United States	$0.348B	0.00
Collegium Pharmaceutical (COLL)	United States	$0.346B	0.00
Xeris Pharmaceuticals (XERS)	United States	$0.331B	0.00
KalVista Pharmaceuticals (KALV)	United States	$0.305B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.288B	0.00
Molecular Templates (MTEM)	United States	$0.272B	0.00
Concert Pharmaceuticals (CNCE)	United States	$0.256B	0.00
OptiNose (OPTN)	United States	$0.250B	0.00
La Jolla Pharmaceutical (LJPC)	United States	$0.236B	0.00
Lannett Co Inc (LCI)	United States	$0.235B	2.28
Recro Pharma (REPH)	United States	$0.220B	0.00
AcelRx Pharmaceuticals (ACRX)	United States	$0.215B	0.00
Ocular Therapeutix (OCUL)	United States	$0.195B	0.00
ASSERTIO THERAPEUTICS, INC (ASRT)	United States	$0.193B	0.00
Redhill Biopharma (RDHL)	Israel	$0.178B	0.00
Nature's Sunshine Products (NATR)	United States	$0.175B	56.63
Taiwan Liposome (TLC)	Taiwan	$0.163B	0.00
Calithera Biosciences (CALA)	United States	$0.162B	0.00
Ardelyx (ARDX)	United States	$0.157B	0.00
IMV INC (IMV)	Canada	$0.152B	0.00
Oasmia Pharmaceutical AB (OASM)	Sweden	$0.151B	0.00
Jounce Therapeutics (JNCE)	United States	$0.136B	0.00
Majesco Entertainment (PTE)	United States	$0.132B	0.00
MEI Pharma (MEIP)	United States	$0.131B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.131B	0.00
Foamix Pharmaceuticals (FOMX)	Israel	$0.126B	0.00
DURECT (DRRX)	United States	$0.118B	0.00
ALLERGY THERAPT (AGYTF)	United Kingdom	$0.108B	0.00
Generex Biotechnology (GNBT)	United States	$0.107B	0.00
Aquestive Therapeutics (AQST)	United States	$0.103B	0.00
MediWound (MDWD)	Israel	$0.101B	0.00
RENEURON GP (RNUGF)	United Kingdom	$0.100B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.093B	0.00
Infinity Pharmaceuticals (INFI)	United States	$0.092B	0.00
Mast Therapeutics (SVRA)	United States	$0.089B	0.00
Champions Oncology (CSBR)	United States	$0.089B	768.00
Genocea Biosciences (GNCA)	United States	$0.089B	0.00
Capnia (SLNO)	United States	$0.088B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.088B	63.00
Nivalis Therapeutics (ALPN)	United States	$0.088B	0.00
Avadel Pharmaceuticals (AVDL)	Ireland	$0.086B	0.00
Entasis Therapeutics Holdings (ETTX)	United States	$0.083B	0.00
Cardiome Pharma (CORV)	Canada	$0.080B	0.00
Natural Alternatives (NAII)	United States	$0.079B	7.90
Otonomy (OTIC)	United States	$0.077B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.075B	0.00
Bellicum Pharmaceuticals (BLCM)	United States	$0.074B	0.00
Novan (NOVN)	United States	$0.070B	0.00
Neos Therapeutics (NEOS)	United States	$0.070B	0.00
Pharmaxis (PXSLY)	Australia	$0.067B	0.00
SCYNEXIS (SCYX)	United States	$0.066B	0.00
Adamis Pharmaceuticals (ADMP)	United States	$0.055B	0.00
Dipexium Pharmaceuticals (PLXP)	United States	$0.055B	0.00
Medicure (MCUJF)	Canada	$0.053B	0.00
Opiant Pharmaceuticals (OPNT)	United States	$0.051B	0.00